- Report
- July 2024
- 280 Pages
Global
From €3278EUR$3,600USD£2,824GBP
- Report
- April 2024
- 356 Pages
Global
From €3278EUR$3,600USD£2,824GBP
- Report
- June 2025
- 150 Pages
Global
From €4416EUR$4,850USD£3,805GBP
- Report
- October 2025
- 95 Pages
Indonesia
From €4416EUR$4,850USD£3,805GBP
- Report
- October 2025
- 94 Pages
Bahrain
From €4416EUR$4,850USD£3,805GBP
- Report
- October 2025
- 90 Pages
Saudi Arabia
From €4416EUR$4,850USD£3,805GBP
From €4416EUR$4,850USD£3,805GBP
- Report
- October 2025
- 100 Pages
Netherlands
From €4416EUR$4,850USD£3,805GBP
- Report
- October 2025
- 93 Pages
India
From €4416EUR$4,850USD£3,805GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£745GBP

The AI Pathology market is a subset of the Diagnostics industry, focusing on the use of artificial intelligence (AI) to aid in the diagnosis of diseases. AI Pathology is a rapidly growing field, with AI-based solutions being used to improve accuracy and speed of diagnosis, as well as to reduce the cost of pathology services. AI Pathology solutions are used to analyze medical images, such as histology slides, to detect and classify diseases. AI Pathology solutions can also be used to detect and classify rare diseases, which can be difficult to diagnose using traditional methods.
AI Pathology solutions are being used in a variety of healthcare settings, including hospitals, clinics, and research laboratories. AI Pathology solutions are also being used to improve the accuracy of diagnosis and to reduce the time required for diagnosis.
Some companies in the AI Pathology market include PathAI, Paige.AI, Viz.ai, and Arterys. Show Less Read more